Informa Pharma Intelligence Archives | Be Korea-savvy
Informa Pharma Intelligence and The American Society of Gene & Cell Therapy (ASGCT) Launches Gene, Cell & RNA Therapy Landscape Q1 2022 Quarterly Data Report

Informa Pharma Intelligence and The American Society of Gene & Cell Therapy (ASGCT) Launches Gene, Cell & RNA Therapy Landscape Q1 2022 Quarterly Data Report

NEW YORK, April 28 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and The American Society of Gene & Cell Therapy (ASGCT), today announced the launch of the Gene, Cell & RNA Therapy Landscape Q1 2022 Quarterly Data Report. The Q1 2022 report assesses industry trends by examining approved gene, [...]

Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review

Informa Pharma Intelligence Launches 30th Edition Pharma R&D Annual Review

NEW YORK, March 24 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, today announced the launch of its 30th Edition Pharma R&D Annual Review. The 2022 report assesses industry trends by examining the pharmaceutical pipeline by company, therapeutic area, disease, target, and drug type, using data from Pharma Intelligence’s Pharmaprojects, part [...]

Informa Pharma Intelligence Launches Preferred Partner Network to Provide Enhanced Specialist Support for Customers’ Content and Technology Needs

Informa Pharma Intelligence Launches Preferred Partner Network to Provide Enhanced Specialist Support for Customers’ Content and Technology Needs

NEW YORK, Nov. 17 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, announced the launch of its Preferred Partner Network to enhance the services supplied to customers across the drug development lifecycle. Built on Informa Pharma’s deep industry expertise and years of collaborating with like-minded companies, the network will [...]

TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process

TrialScope Atlas Helps Sponsors Reduce Risk, Manage the Complicated Global Clinical Trial Disclosure Process

NEW YORK, Oct. 26 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, has launched TrialScope Atlas, a single, searchable dashboard that automates clinical trial disclosure and consolidates a concise set of relevant regulations. Clinical trial sponsors are under increased pressure to maintain regulatory disclosure compliance, for several reasons: The EU [...]

Informa Pharma Intelligence Partners with ICON to Launch an Integrated Predictive Analytic Solution for Clinical Trial Feasibility

Informa Pharma Intelligence Partners with ICON to Launch an Integrated Predictive Analytic Solution for Clinical Trial Feasibility

NEW YORK, Oct. 13 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, today announced its partnership with ICON plc, one of the world’s leading contract research organizations (CROs), to elevate its cutting-edge, predictive analytic solution for clinical trial feasibility planning — Citeline Study Feasibility. Informa Pharma Intelligence will combine its best-in-class [...]

Informa Pharma Intelligence Launches Citeline Study Feasibility to Accelerate Clinical Trial Timelines

Informa Pharma Intelligence Launches Citeline Study Feasibility to Accelerate Clinical Trial Timelines

NEW YORK, June 16 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, today announced the launch of Citeline Study Feasibility – an AI-driven platform that delivers predictive analytics to improve clinical trial decisions and cycle times. By combining its best-in-class data sets with machine learning capabilities, this solution will [...]

Informa Pharma Intelligence Launches New Pulse Report: Clinical Trials & the COVID-19 Vaccine

Informa Pharma Intelligence Launches New Pulse Report: Clinical Trials & the COVID-19 Vaccine

LONDON, Oct. 1 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, today released its “Pulse Report: Clinical Trials & the COVID-19 Vaccine” study which uncovered American sentiment and confidence around COVID-19 vaccine clinical trials. According to the data, more than 1 in 3 (35%) Americans don’t trust how quickly the COVID-19 [...]

Informa Pharma Intelligence Announces COVID-19 24-Hour Webinar Series

Informa Pharma Intelligence Announces COVID-19 24-Hour Webinar Series

LONDON, June 23 (Korea Bizwire) – Informa Pharma Intelligence, today announces an upcoming free 24-hour interactive webinar series entitled COVID-19 24-hour Web Event: Lessons Learned and a Path Forward. The event will cover the latest insights and learnings on COVID-19 from across the global pharma and biomedtech industries, starting at 9:00 am BST on July 21st, 2020. [...]

Informa Pharma Intelligence Names Ramsey Hashem as President

Informa Pharma Intelligence Names Ramsey Hashem as President

LONDON, June 17 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence leader for the biopharma industry, today announced that, effective July 1, Ramsey Hashem, Informa Pharma Intelligence’s Chief Commercial Officer, has been named President. Hashem will assume the role from Linda Blackerby, who is moving into non-executive roles after 11 years of successful service [...]

Signals Analytics Powers Informa Pharma Intelligence’s Offerings with Next Generation Advanced Analytics

Signals Analytics Powers Informa Pharma Intelligence’s Offerings with Next Generation Advanced Analytics

NEW YORK, April 22 (Korea Bizwire) – Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and Signals Analytics, the next generation advanced analytics platform that leverages external data to uncover trends and novel insights, today announced a joint offering that helps life sciences companies to identify new opportunities, mitigate investment risks and accelerate the [...]